Morgan Stanley’s Pfizer PFE Stock Holding History

Morgan Stanley’s Portfolio PFE Stock Details PFE Fund Activity

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$1.7B	Sell	70,135,308 -10,307,009	-13%	-$250M	0.11%	163
2025 Q1	$2.04B	Buy	80,442,317 +6,544,527	+9%	+$166M	0.15%	125
2024 Q4	$1.96B	Sell	73,897,790 -4,073,426	-5%	-$108M	0.14%	129
2024 Q3	$2.26B	Buy	77,971,216 +498,970	+0.6%	+$14.4M	0.16%	111
2024 Q2	$2.17B	Sell	77,472,246 -7,320,593	-9%	-$205M	0.17%	111
2024 Q1	$2.35B	Sell	84,792,839 -79,420,233	-48%	-$2.2B	0.19%	96
2023 Q4	$4.73B	Buy	164,213,072 +79,285,270	+93%	+$2.28B	0.21%	90
2023 Q3	$2.82B	Buy	84,927,802 +348,628	+0.4%	+$11.6M	0.29%	59
2023 Q2	$3.1B	Buy	84,579,174 +3,929,745	+5%	+$144M	0.31%	55
2023 Q1	$3.29B	Buy	80,649,429 +1,150,068	+1%	+$46.9M	0.35%	51
2022 Q4	$4.07B	Buy	79,499,361 +7,419,929	+10%	+$380M	0.46%	35
2022 Q3	$3.15B	Sell	72,079,432 -469,003	-0.6%	-$20.5M	0.43%	40
2022 Q2	$3.8B	Buy	72,548,435 +25,173,688	+53%	+$1.32B	0.49%	32
2022 Q1	$2.45B	Buy	47,374,747 +320,901	+0.7%	+$16.6M	0.33%	62
2021 Q4	$2.78B	Buy	47,053,846 +399,821	+0.9%	+$23.6M	0.34%	59
2021 Q3	$2.01B	Sell	46,654,025 -1,240,055	-3%	-$53.3M	0.27%	86
2021 Q2	$1.88B	Buy	47,894,080 +1,582,052	+3%	+$62M	0.25%	94
2021 Q1	$1.68B	Sell	46,312,028 -7,298,083	-14%	-$264M	0.25%	95
2020 Q4	$1.97B	Buy	53,610,111 +7,540,245	+16%	+$278M	0.3%	71
2020 Q3	$1.69B	Buy	46,069,866 +2,777,676	+6%	+$102M	0.33%	71
2020 Q2	$1.42B	Sell	43,292,190 -2,111,897	-5%	-$69.1M	0.31%	78
2020 Q1	$1.48B	Sell	45,404,087 -1,944,379	-4%	-$63.5M	0.4%	55
2019 Q4	$1.86B	Buy	47,348,466 +2,492,660	+6%	+$97.7M	0.43%	37
2019 Q3	$1.61B	Sell	44,855,806 -1,680,971	-4%	-$60.4M	0.43%	36
2019 Q2	$2.02B	Buy	46,536,777 +1,071,897	+2%	+$46.4M	0.54%	23
2019 Q1	$1.93B	Sell	45,464,880 -4,470,687	-9%	-$190M	0.55%	20
2018 Q4	$2.18B	Sell	49,935,567 -5,558,279	-10%	-$243M	0.65%	15
2018 Q3	$2.45B	Buy	55,493,846 +1,126,612	+2%	+$49.6M	0.61%	17
2018 Q2	$1.97B	Buy	54,367,234 +1,345,528	+3%	+$48.8M	0.53%	24
2018 Q1	$1.88B	Buy	53,021,706 +3,102,438	+6%	+$110M	0.52%	23
2017 Q4	$1.81B	Buy	49,919,268 +2,953,018	+6%	+$107M	0.49%	25
2017 Q3	$1.68B	Sell	46,966,250 -160,235	-0.3%	-$5.72M	0.5%	25
2017 Q2	$1.58B	Sell	47,126,485 -2,550,664	-5%	-$85.7M	0.48%	28
2017 Q1	$1.7B	Buy	49,677,149 +4,042,608	+9%	+$138M	0.52%	22
2016 Q4	$1.48B	Buy	45,634,541 +6,262,794	+16%	+$203M	0.49%	28
2016 Q3	$1.33B	Buy	39,371,747 +2,869,456	+8%	+$97.2M	0.46%	26
2016 Q2	$1.29B	Buy	36,502,291 +789,962	+2%	+$27.8M	0.46%	26
2016 Q1	$1.06B	Sell	35,712,329 -1,701,078	-5%	-$50.4M	0.41%	35
2015 Q4	$1.21B	Buy	37,413,407 +1,679,910	+5%	+$54.2M	0.44%	25
2015 Q3	$1.12B	Buy	35,733,497 +1,684,290	+5%	+$52.9M	0.41%	27
2015 Q2	$1.14B	Sell	34,049,207 -1,095,484	-3%	-$36.7M	0.4%	35
2015 Q1	$1.22B	Buy	35,144,691 +438,641	+1%	+$15.3M	0.45%	24
2014 Q4	$1.08B	Buy	34,706,050 +302,242	+0.9%	+$9.41M	0.4%	31
2014 Q3	$1.02B	Sell	34,403,808 -9,701	-0%	-$287K	0.39%	29
2014 Q2	$1.02B	Buy	34,413,509 +3,298,956	+11%	+$97.9M	0.4%	27
2014 Q1	$999M	Buy	31,114,553 +256,773	+0.8%	+$8.25M	0.42%	24
2013 Q4	$945M	Buy	30,857,780 +266,813	+0.9%	+$8.17M	0.4%	33
2013 Q3	$879M	Sell	30,590,967 -8,920,422	-23%	-$256M	0.42%	29
2013 Q2	$1.11B	Buy	+39,511,389	New	+$1.11B	0.56%	16